Patents by Inventor Katja Wosikowski

Katja Wosikowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
    Patent number: 6506572
    Abstract: New biologically active compounds are described which inhibit the cellular formation of niacinamide mononucleotide, and essential intermediate of the NAD(P) biosynthesis in the cell. These compounds can represent the active ingredient of a pharmaceutical composition for the treatment of cancers, leukaemias or for immunosuppression. Furthermore, screening methods are described as a tool for detecting the above active compounds, and for examination of a given cell type for its dependency on niacinamide as a precursor for NAD synthesis.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: January 14, 2003
    Assignee: Klinge Pharma GmbH
    Inventors: Elfi Biedermann, Rolf Eisenburger, Max Hasmann, Roland Löser, Benno Rattel, Friedemann Reiter, Barbara Schein, Isabel Schemainda, Michael Schulz, Klaus Seibel, Klaus Vogt, Katja Wosikowski
  • Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
    Publication number: 20020160968
    Abstract: New biologically active compounds are described which inhibit the cellular formation of niacinamide mononucleotide, and essential intermediate of the NAD(P) biosynthesis in the cell. These compounds can represent the active ingredient of a pharmaceutical composition for the treatment of cancers, leukaemias or for immunosuppression. Furthermore, screening methods are described as a tool for detecting the above active compounds, and for examination of a given cell type for its dependency on niacinamide as a precursor for NAD synthesis.
    Type: Application
    Filed: August 23, 2001
    Publication date: October 31, 2002
    Applicant: Klinge Pharma GmbH
    Inventors: Elfi Biedermann, Rolf Eisenburger, Max Hasmann, Roland Loser, Benno Rattel, Friedemann Reiter, Barbara Schein, Isabel Schemainda, Michael Schulz, Klaus Seibel, Klaus Vogt, Katja Wosikowski